Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Bioactive Compounds

Bioactive Compounds

Items 8711-8720 of 13159

Page
per page
  1. TG101209
    A4145 TG101209
    Summary: JAK2/3 inhibitor
      ≥25.5 mg/mL
  2. LAQ824 (NVP-LAQ824,Dacinostat)
    A4103 LAQ824 (NVP-LAQ824,Dacinostat)
     1 Citation
    Summary: HDAC inhibitor,potent and novel
      insoluble in H2O; insoluble in EtOH; ≥17.45 mg/mL
  3. GSK1070916
    A4127 GSK1070916
    Target: Aurora Kinases
    Summary: Aurora B/C inhibitor
      ≥25.4 mg/mL
  4. Bromodomain Inhibitor, (+)-JQ1
    A1910 Bromodomain Inhibitor, (+)-JQ1
     69 Citation
    Target: Bromodomains
    Summary: BET bromodomain inhibitor
      ≥22.85 mg/mL
  5. S- (+)-Rolipram
    A4349 S- (+)-Rolipram
    Summary: CAMP-specific PDE4 inhibitor
      insoluble in H2O; ≥13.9 mg/mL
  6. Doramectin
    A3371 Doramectin
    Summary: Antiparasitic antibiotic
      ≥89.9 mg/mL
  7. RS 127445
    A3778 RS 127445
    Summary: 5-HT2B receptor antagonist,high affinity
      insoluble in H2O; ≥15.89 mg/mL
  8. CTOP TFA
    A8975 CTOP TFA
      Soluble in DMSO
  9. Thalidomide-4-OH
    C6597 Thalidomide-4-OH
      ≥51.2 mg/mL
  10. 3-Phenoxybenzoic acid
    C6603 3-Phenoxybenzoic acid
      ≥37.9 mg/mL

Items 8711-8720 of 13159

Page
per page